Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11230600 Anti-B7-H4 antibodies and immunoconjugates

Patent 11230600 was granted and assigned to Genentech on January, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

112306000

Patent Inventor Names

Wei-Ching Liang0

Yan Wu0

Andrew Polson0

Paul Polakis0

Ron Firestein0

Steven R. Leong0

Date of Patent

January 25, 2022

Patent Application Number

161670000

Date Filed

October 22, 2018

Patent Citations

‌

US Patent 10059768 Anti-B7-H4 antibodies and immunoconjugates

‌

US Patent 10150813 Anti-B7-H4 antibodies and immunoconjugates

Patent Citations Received

‌

US Patent 12134649 Anti-B7-H4 antibodies and immunoconjugates

Patent Primary Examiner

‌

Ilia I Ouspenski

Patent abstract

The invention provides anti-B7-H4 antibodies and immunoconjugates and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11230600 Anti-B7-H4 antibodies and immunoconjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API